Sio Capital Management’s Biogen BIIB Stock Holding History

Sio Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,800	Closed	-$3.69M	–	91
2020 Q2	$3.69M	Buy	+13,800	New	+$4.15M	1.08%	37

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Sio Capital Management's BIIB Position: Q3 2022 in Review

Sio Capital Management sold out of Biogen (BIIB) in Q3 2022, closing a stake of 35,900 shares — an estimated $7.32M sold.

Sio Capital Management first reported a position in BIIB in Q2 2016 and held it in 9 quarters. The position peaked at $18.6M in Q1 2019. 987 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

Sio Capital Management reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
Sio Capital Management sold 35,900 Biogen shares in Q3 2022, an estimated $7.32M.
Sio Capital Management first reported a position in Biogen in Q2 2016 and held it in 9 quarters.
Sio Capital Management's Biogen position peaked at $18.6M in Q1 2019.
987 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Sio Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.